The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...